Testing a new epilepsy medicine in healthy adults
Treatments studied
This study tests a new medicine, EPX-100, for epilepsy in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a non-smoker and have not used any tobacco or nicotine products for at least 3 months.
- You must be in good general health with no significant medical conditions.
- Your body mass index must be between 18 and 32.
- You must not have had your gallbladder removed.
- You must not have a personal or family history of certain heart rhythm problems or sudden cardiac death.
- You must not have a history of seizures, epilepsy, or other significant neurological conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called SIF001 for safety. It first gives the medicine to healthy volunteers, and then to people with epilepsy who have seizures even while on their current medicines. The goal is to find a safe dose.
This study gives XEN1101 in an open-label way (everyone knows they’re getting the drug) to people who finished earlier epilepsy studies. It aims to see how the treatment continues to work and whether it’s safe over the long term.
This study tests an experimental pill called PRAX-628 for adults whose seizures are not fully controlled by current medications. It aims to see if the drug is safe and effective at reducing seizures.
This trial tests XEN1101 compared with a placebo (inactive pill) in people with focal-onset seizures that haven’t been fully controlled despite trying at least two anti-seizure medicines. If you qualify, you may help researchers see whether the study drug reduces seizure frequency and improves control.
This study tests a new experimental medication (QX-4533) in healthy volunteers to find the best dose and see how it works in the body. It involves taking the medication and having your health monitored closely over time.
This trial tests a new medication, CB03-154, to see if it is safe and can reduce seizures in adults with focal epilepsy. You may be able to join if you have had focal epilepsy for at least 2 years and are on a stable dose of 1 to 3 anti-seizure medications.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.